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          The chemical stability of flutamide (FLT) was investigated using a new validated stability-
indicating HPLC method. Separation of FLT from its degradation product was achieved on a C18 
column using a mobile phase of methanol-phosphate buffer (0.04 M, pH 4.0) (75:25, v/v) with UV-
detection at 240 nm. The method exhibited excellent linearity for FLT over the concentration range of 
0.2-25.0 µg/mL. FLT was found to be labile to degradation in buffered, acidic and alkaline solutions. 
The degradation kinetics of FLT in aqueous solutions was evaluated as a function of pH and 
temperature. Degradation of FLT followed first-order kinetics and Arrhenius behavior over the 
temperature ranges of 70-100 and 60-90 °C under acidic and alkaline conditions. The pH-rate profile 
was studied over the pH range of 2–12 with a maximum stability at pH 3.0-5.0. The activation energy 
for hydrolysis of FLT was calculated as 79.4 and 52.0 kJ/mol at pH 0.5 (0.3 M HCl) and 12.5 (0.03 M 
NaOH), respectively. 4-Nitro-3-trifluoromethyl aniline was identified by mass spectrometry to be the 
degradation product resulted from the hydrolysis of FLT. The proposed HPLC method was validated 
according to ICH guidelines and applied for the quality control of FLT in commercial tablets with 
mean percentage recovery of 100.09±0.20%.  
 
 






          Flutamide (FLT), propanamide, 2-methyl-N-[4-nitro-3-trifluoromethyl)-phenyl] [1], is a non-
steroidal drug with anti-androgenic properties which appears to act by inhibiting the uptake and/or 
binding of androgens in target tissues. It is used, usually with gonadorelin analogues, in the palliative 
treatment of prostatic carcinoma. It is also used in combination with testolactone for the treatment of 
congenital adrenal hyperplasia [2]. 
          FLT is an official drug in the United States Pharmacopoeia (USP) [1] that recommends an 
HPLC method for its determination in pure state and capsules. Also, it is authorized in the British 
Pharmacopoeia (BP) [3] that describes a direct spectrophotometric assay at 295 nm for its 
determination in pure from. Reviewing the literature revealed some analytical methods for the 
determination of FLT such as spectrophotometry [4-7], HPLC [8-10], voltammetry [11-13], and GC-
electron capture detection [14]. Few analytical methods studied the stability of FLT [15, 16]. 
Nevertheless, such methods did not study the kinetics of the degradation process or elucidate the 
chemical structure of FLT degradant. So far, no study elucidated the pH-rate profile of FLT despite it 
provides useful information for the optimal formulation and storage conditions of pharmaceutical 
products [17]. This encouraged us to develop a simple, rapid and accurate stability-indicating HPLC 
method for FLT with main targets of (i) studying its degradation kinetics, (ii) identification of possibly 
formed degradation products under different International Conference on Harmonisation (ICH)-
outlined stress conditions [18, 19], and (iii) elucidation of its pH-rate profile curve.  
   
Experimental  
Instruments 
          Chromatographic separation was achieved with a Hitachi HPLC system (Tokyo, Japan) 
equipped with 655A-11 liquid chromatograph, a high sensitivity series L-4000 H UV-detector, D-2500 
chromato-integrator, LC-organizer and a Rheodyne injector valve with a 50-µL sample loop. Positive 
electron ionization mass spectra (EI+-MS) were recorded using JMS DX-303 mass spectrometer (Joel 
Ltd., Japan). SK-620 pH/mV meter (Sato Keiryoki MFG Co. Ltd, China) was used for pH adjustment. 
A BT-15 Yamato thermostatically controlled water bath (Tokyo, Japan) was used in the stability 






Chemicals and reagents 
          A gift sample of flutamide with a certified purity of 98.82% (batch # 9007) was kindly provided 
by Schering-Plough Co. (Cairo, Egypt). Cytomid® tablets labeled to contain 250 mg FLT/tablet 
(product of Cipla Ltd., Mumbai, India) was purchased from a local Egyptian pharmacy. Methanol 
(HPLC grade) was obtained from Kanto Chemical Co., INC. (Tokyo, Japan). Orthophosphoric acid 
(85% w/v) and potassium dihydrogen phosphate were obtained from Wako Pure Chemical Industries, 
Ltd. (Osaka, Japan). Hydrochloric acid (35-37%) and sodium hydroxide were obtained from 
Chameleon Reagent (Osaka, Japan). Hydrogen peroxide (30% w/v) was obtained from Nacalai 
Tesque, Inc. (Kyoto, Japan). Purified water was obtained using Millipore direct-Q 3UV water 
purification system (Molsheim, France). Aqueous solutions of 0.3 M HCl and 0.03 M NaOH were 
prepared. Phosphate buffer of pH 4.0 was prepared by adjusting the pH of 0.04 M potassium 
dihydrogen phosphate with few drops of orthophosphoric acid (85% w/v). Britton-Robinson buffer 
(BRB) containing 0.04 M boric acid, 0.04 orthophosphoric acid, and 0.04 M acetic acid was prepared 
and the pH was adjusted to 2-12 with 0.2 M NaOH [20]. 
Standard solution 
          A stock solution of FLT containing 2000.0 µg/mL was prepared in methanol. A standard 
solution (200.0 µg/mL) was prepared by dilution with the same solvent. The solutions were stable for 
one week when stored in a refrigerator at 4 °C. 
Chromatographic conditions 
          Separation was performed on a Cosmosil 5C18-MS column (150 mm x4.6 mm id, 5-µm particle 
size) from Nacalai Tesque, Inc. A mobile phase consisted of methanol-phosphate buffer (0.04 M; pH 
4.0) (75:25, v/v) was pumped at a flow rate of 1 mL/min and UV-detection was set at 240 nm. 
Calculation of degradation kinetics parameters 
          Kinetics parameters for the degradation of FLT were calculated [21]. The observed first-order 
degradation rate constants (k) were calculated from the slopes of semi-logarithmic plots of log a
a−x
 
versus time (t) in accordance with Eq. (1): 
kt = 2.303 log a
a−x
 .                                                             (1) 
Where (a) is the initial drug concentration and (a-x) is the remaining drug concentration.  
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.                                                                           (2) 
          Activation energy (Ea) was calculated from the slope of Arrhenius plot of log k versus 1/T in 
accordance to Eq. (3): 
log k = log A –  Ea
2.303 RT
 .                                                       (3)                     
Where: R is the gas constant = 8.314 J/mol/K and T is the absolute temperature (°K = 273 + ºC). 
General recommended procedures 
Calibration graph. Accurately measured volumes of FLT standard solution (200.0 µg/mL) were 
diluted with the mobile phase to obtain final concentrations over the range of 0.2-25.0 µg/mL. Twenty 
µL aliquots were injected (triplicate) and eluted with the mobile phase under the optimum 
chromatographic conditions. The average peak areas of FLT were plotted versus the corresponding 
drug concentrations (µg/mL) and the regression equation was derived. 
Assay of tablets. Ten tablets were accurately weighed, finely pulverized and thoroughly mixed. An 
accurately weighed amount of the powder equivalent to 10.0 mg FLT were transferred into 100 mL 
volumetric flask and diluted to the mark with methanol. The solution was sonicated for 30 min then 
filtered. Accurately measured volumes of the filtrate were diluted with the mobile phase and 
chromatographed under the optimum conditions. Nominal contents of FLT were calculated using the 
regression equation.  
Degradation protocol. 0.5 mL aliquots of FLT standard solution (200.0 µg/mL) were transferred into 
a series of 10 mL glass vials followed by 2 mL of 0.3 M HCl or 0.03 M NaOH. Solutions were then 
incubated in a thermostatically controlled water bath at different temperature settings (70-100 and 60-
90°C for acidic and alkaline degradation, respectively). Samples were taken at appropriate times (10-
40 min), neutralized and made up to 5.0 mL with the mobile phase and mixed well.  Samples were 
eluted under the optimum chromatographic conditions and the remaining drug concentrations were 
calculated using the regression equation. A plot of log a
a−x
  versus time (t) was constructed.  The 
observed first-order degradation rate constants (k) and half-lives (t1/2), were calculated using Eqs. (1) 
and (2), respectively. Arrhenius plot was constructed by plotting Log k versus 1/T (°K) and the 
activation energy (Ea) for FLT degradation was calculated from the slope according to Eq. (3). 
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          Oxidative stress study was also carried out as follow: 2 mL of H2O2 (30, w/v) were added to 50 
µL of FLT stock solution and heated for 2 h at 80°C. For the photo-degradation study; 50 µL of FLT 
stock solution was transferred into a series of glass vials and diluted with 2 mL of methanol, water or 
methanol-water mixture (1:1, v/v), then exposed to UV-lamp emitting radiation at a wavelength of 254 
nm for 24 h. Then, the solutions were made up to 5 mL with the mobile phase, mixed well and eluted 
under the optimum chromatographic conditions. 
pH-rate profile for FLT. 1 mL of FLT stock solution (2000.0 µg/mL) was transferred into a series of 
10 mL glass vials, 9 mL of BRB (pH = 2-12) were added and mixed well. Solutions were heated under 
reflux in a boiling water bath. 1 mL aliquots were taken at appropriate times (10-40 min), neutralized 
and diluted to 10 mL with the mobile phase then analyzed. The remaining drug concentrations were 
calculated from the regression equation. A plot of log a
a−x
  versus time (t) was constructed and the 
observed reaction rate constants (k) were calculated using Eq. (1). The pH-rate profile curve was 
constructed by plotting log k versus pH of BRB.  
Results and Discussion 
          HPLC degradation studies of FLT revealed its stability under neutral, oxidative and photolytic 
conditions. Meanwhile, it was found susceptible to degradation under acidic and alkaline conditions 
yielding the same degradation product (DP). Hence, a kinetic study was conducted to explore the 
degradation process and pH-rate profile curve was also constructed. 
Method development 
          The pH, composition, and flow rate of the mobile phase as well as detection wavelength were 
optimized to achieve good separation of FLT from its stress induced degradation product (DP) with 
high sensitivity. For optimization of HPLC conditions, stressed samples of FLT under acidic (0.3 M 
HCl) and alkaline (0.03 M NaOH) conditions at 80 °C for 30 min were chromatographed.  
          The pH of phosphate buffer was tested over the range of 3.0-7.0. It was found that, changing the 
pH exhibits a negligible effect on the retention of the drug and its degradation product. Hence, this 
study was conducted using phosphate buffer of pH 4.0 to confirm maximum stability and durability of 
the column. The percentage of methanol in the mobile phase was also studied over the range of 60-
80 %, v/v. A mobile phase containing 75%, v/v methanol was selected as the optimal yielding good 
resolution between FLT and DP within a short analysis time (less than 5 min). At lower concentrations 
of methanol, the retention times of both FLT and DP increased with a distinct effect on FLT. 
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Meanwhile, on increasing the percentage of methanol to 80%, v/v, the retention of both components 
decreased (especially of FLT) and the resolution between FLT and DP was adversely affected. 
Studying the influence of ionic strength of phosphate buffer over the range of 0.01-0.05 M revealed no 
significant effect on the separation process, 0.04 M phosphate buffer was used in the present study. 
Flow rate of the mobile phase was also studied (0.8-1.2 mL/min) and a flow rate of 1.0 mL/min was 
selected as optimal giving good resolution within short analysis time. Detector wavelength was 
investigated by monitoring the eluents responses at different wavelength settings (215, 240, 254 and 
295 nm). Best sensitivities for both FLT and degradation product were attained at 240 nm. A summary 
of the influence of different chromatographic parameters on system suitability is illustrated in Table 1. 
Under the optimum chromatographic conditions, good resolution was achieved between the drug (tR = 
4.0 min) and its degradation product (tR = 2.44 min) within a short analysis time.  
          A comparison between the analytical performance of the proposed HPLC method and methods 
reported in the literature for the determination of FLT is presented in Table 2.  
Method validation 
          A validation procedure was conducted according to ICH guidelines [22] to evaluate linearity, 
range, limit of detection, limit of quantification, accuracy, precision, selectivity, robustness, system 
suitability, and stability of standard solution and mobile phase. 
Linearity and range. Eight concentration levels were considered to study the linearity. Regression 
analysis of the data [23] proved the excellent linearity of the proposed method over a wide dynamic 
range (0.2-25.0 µg/mL) as revealed by high value of correlation coefficient (r=0.9999), small values of 
the standard deviations of the residuals (Sy/x), slope (Sb), and intercept (Sa), and the % relative error. 
Table 3 illustrates the linear regression analysis data for FLT.  
 
Limit of detection (LOD) and limit of quantification (LOQ). Both LOD and LOQ were calculated 
as per ICH guidelines [22] according to the following equations: 
(4)                                /baLOQ = 10S 
(5)                               /baLOD = 3.3S 
Where Sa = the standard deviation of the intercept of regression line and b = the slope of regression 




 Accuracy. Accuracy of the proposed method was determined by recovery studies. The method was 
demonstrated to be accurate giving average recovery of 100.63±1.40%. Statistical comparison of the 
obtained results with those of the reference HPLC method [1] using the Student’s t-test and the 
variance ratio F-test was done [23]. Both the t- and the F- values obtained at the 95% confidence level, 
did not exceed the theoretical tabulated values [23]. Therefore, there is no significant difference 
between the proposed and reference methods [1] regarding the accuracy and precision (Table 4). 
 
Precision .The repeatability (intra-day precision) studies were performed by analysis of FLT at three 
concentration levels at three successive times on the same day, whereas, intermediate precision (inter-
day precision) was checked by repeating the analysis of the three drug concentrations on three 
consecutive days. The precision was expressed as %RSD. Results of precision studies summarized in 
Table 5 confirm the precision of the method. 
 
Selectivity. Results of the forced degradation studies revealed the ability of the proposed method to 
entirely separate the drug from its degradation product with a good resolution factor (Rs). In addition 
no interference from common pharmaceutical excipients in the tablets with the peak of the drug was 
observed. These results indicated the selectivity of the proposed method. 
 
Robustness. To determine the robustness of the proposed method with deliberated minor changes in 
chromatographic conditions, four parameters were varied: pH of the mobile phase (4.0±0.2), ratio of 
methanol (75±2 %, v/v), molarity of phosphate buffer (0.04±0.001M) and detection wavelength 
(240±2 nm). Introducing these small but deliberate variations didn't significantly affect the resolution 
or peak area of the analyte. These results demonstrated the robustness of the developed method. 
System suitability. The system suitability parameters including Rs, number of theoretical plates (N), 
retention factor (k), selectivity factor (α) were calculated according to USP guidelines [1]. The results 
are illustrated in Table 6. 
 
Stability of standard solution and mobile phase. Comparing the analytical response of freshly-
prepared standard solution of FLT with that of an aged solution (24 h at room temperature) revealed 
the stability of the standard solution over this period. Similarly, the mobile phase was found to be 




 Degradation behavior of FLT under ICH conditions. FLT exhibited a high stability under 
photolytic, neutral hydrolysis and oxidative stress conditions, while it underwent rapid degradation 
under acidic and alkaline conditions yielding the same degradation product (DP). Figure 1 illustrates 
representative chromatograms of FLT after acidic and alkaline treatments. Degradation of FLT in 
acidic and alkaline conditions followed first-order kinetics (Fig 2), and the degradation process obeyed 
Arrhenius behavior over the temperature ranges of 70-100 and 60-90 °C under acidic and alkaline 
conditions, respectively. Linear plots for Arrhenius equations for the acidic and alkaline degradation 
were obtained as illustrated in Fig. 3. Table 7 represents a summary of the calculated k, t1/2, Ea and 
Arrhenius equations for FLT degradation in 0.3 M HCl and 0.03 M NaOH. The activation energies Ea 
for the acidic and alkaline degradation of FLT were found to be 79.4 and 52 KJ/mol.  These values are 
within the range of 50–96 KJ/mol most commonly reported and represents an intermediate sensitivity 
of the degradation process to temperature [21].  
          The liability of the drug to hydrolysis under alkaline condition is very high compared with its 
behavior under acidic condition, as revealed from k and Ea values (Table 7). FLT is an anilide 
derivative, in which the amide nitrogen is linked to an aromatic ring which can "pull" electron density 
from this atom, weakening the amide C-N bond. This ring can also stabilize the leaving group by 
delocalization of electron pair on nitrogen. As a result, the amide nitrogen could be attacked easier by 
the hydroxide ion (ŌH) than hydronium ion (H3O+), which rational the liability of the drug to 
hydrolysis under basic conditions more than under acidic conditions. 
 
pH-rate profile of FLT. The degradation of FLT in BRB over pH range of 2.0-12.0 at boiling 
temperature resulted in the appearance of DP as a degradation product. All the correlation coefficients 
(r) of the semi-logarithmic plots of the drug remaining versus time were > 0.98 with most of them > 
0.99 indicating that, the degradation of FLT followed first-order kinetics. The pH-rate profile of FLT 
over the pH range of 2.0–12.0 is illustrated in Fig. 4, showing maximum stability over pH range of 
3.0-5.0. Degradation occurred more rapidly in basic solution with increased rate of degradation upon 
increasing the pH. At pH 3.0-5.0, the estimated degradation rate constant was in the range of 1.2x10-6 
– 1.3x10-6 min-1 giving an estimated half-life (t1/2) of 13.4-12.3 months at 100 °C. In more acidic 
solution (pH 2.0) the degradation rate constant increased to 3.3x10-6 min-1. 
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          The rapidness of the proposed method (separation was achieved within 5 min) together with its 
sensitivity, selectivity, and accuracy, permitted the analysis of large number of samples generated 
from pH-rate profile studies in a short time. 
EI+-MS study of degradation product of FLT. HPLC analysis showed that hydrolysis of FLT in 
BRB and in 0.3 M HCl as well as 0.03 M NaOH solutions produced the same degradation product 
with a constant retention time (2.44 min). The corresponding EI+-MS spectrum of this compound 
yielded an m/z ratio of 206 which is consistent with 4-nitro-3-trifuoromethyl aniline (C7H5F3N2O2) 
formed as a result of hydrolysis of the amide linkage of FLT (Fig 5). Figure 6 illustrates the obtained 
EI+-MS spectra for FLT and its hydrolytic degradation product. 
Quality control of flutamide tablets. The suggested method was successfully applied for the 
determination of FLT in Cytomid® tablets. The results shown in Table 3 were satisfactory and with 
good agreement with the labeled amount. The obtained results indicated stability of FLT under storage 
conditions since no degradation product was detected. The results were statistically compared with 
those obtained by the official HPLC method [1] using Student t- and Variance ration F-tests [23]. 
There was no significant difference between the two methods in terms of the mean values and standard 
deviation at the 95% confidence level (Table 4). The obtained results indicated the suitability of the 
proposed method for the quality control of FLT without interferences from common tablets excipients. 
Conclusion  
          We developed a sensitive, accurate, precise, and rapid HPLC method able to discriminate 
between FLT and its degradation product. FLT was found to be very sensitive to alkaline and acidic 
media. The proposed method was managed to study the degradation kinetics of FLT under alkaline 
and acidic conditions and to elucidate its Arrhenius plots. In addition, the proposed method was 
applied to derive the pH-rate profile curve for FLT in BRB which exhibited highest stability over pH 
3.0-5.0.  
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FLT DP FLT DP 
Ratio of methanol (%, v/v) 
60 11507 14578 10.47 2.23 21.83 4.70 
65 9132 6180 4.11 1.10 13.66 3.74 
70 4282 4343 2.50 0.76 11.04 3.29 
75* 8864 3972 1.52 0.52 6.50 2.92 
80 5744 2633 1.03 0.37 4.24 2.78 
pH 
3.0 8132 3271 1.54 0.52 6.04 2.96 
4.0* 8864 3972 1.52 0.52 6.50 2.92 
5.0 8383 3164 1.27 0.40 6.00 3.18 
6.0 8732 3191 1.34 0.41 5.71 3.27 
7.0 8680 3462 1.49 0.49 6.72 3.04 
Ionic strength of phosphate buffer (M) 
0.01 7659 3380 2.1 0.87 4. 63 2.41 
0.02 9540 3463 1.95 0.79 6.04 2.47 
0.04* 10007 3631 2.38 1.03 6.26 2.31 
0.05 8864 3972 1.52 0.52 6.50 2.92 
Flow rate (mL/min) 
0.8 5697 5053 1. 61 0. 64 5.11 2.52 
1.0* 10010 3642 2.41 1.00 6.30 2.30 
1.2 5816 2305 1.59 0.63 4.53 2.52 
a System suitability parameters were calculated as per USP [1].    




Table 2 Comparison between the proposed and reported methods for FLT. 






4 harsh conditions, multiple derivatization steps, time 






5 harsh conditions, multiple derivatization steps, time 








6 harsh conditions, multiple derivatization steps, time 
consuming, not stability indicating assay 
 
N/A N/A spectrophotometry 
 
7 harsh conditions, multiple derivatization steps, time 










8 poor sensitivity, narrow linearity range, not stability 
indicating assay  
  
N/A 2.9-11.6 HPLC-UV 
9 very narrow linearity range, harsh and multiple steps 







narrow linearity range, not stability indicating assay 0.02 2.0-12.0 HPLC-UV 
11 needs special polymer film modified carbon paste 
 electrode, not stability indicating assay 
 
0.05 20.0-160.0 Voltammetry 











not stability indicating assay, require special 
instrumentation and expertise, high cost 
N/A 0.002-0.3 
0.003-0.5 
electron capture  -GC
Ni) detection63( 
15 longer retention time, alkaline, oxidative, photolytic 
degradation, and pH-rate profile were not studied, DP 
wasn't identified  
 
N/A 0.5-20.0 HPLC-UV 
16 time consuming, degradation kinetics and pH-rate profile 













short retention time, wide linearity range, high 
sensitivity, stability indicating assay, degradation under 
different ICH-conditions was conducted, degradation 
kinetics was studied, pH-rate profile was constructed. 
0.05 0.2-25.0 HPLC-UV 
N/A: data are not available. 
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Table 3 Linear regression analysis data for the determination of FLT by the proposed method 
Parameter Result 
Concentration range (µg/mL)  0.2-25.0 
Limit of detection (LOD) (µg/mL) 0.05 
Limit of quantification (LOQ) (µg/mL) 0.16 
Correlation coefficient (r) 0.9999 
Slope 9.83 x 103 
Intercept 1.22 x 102 
Standard deviation of the residuals (Sy/x) 6.65 x 102 
Standard deviation of the intercept (Sa) 1.61 x 102 
Standard deviation of the slope (Sb) 26.01 
% RSD 1.39 






Table 4 Application of the proposed and reference methods for the determination of FLT in pure 
form and tablets 
 
Matrix  
Proposed method Reference  
method [1] 




% Founda % Founda 
Pure form 
 
0.2 0.202 101.00 99.05 
0.4 0.407 101.75 100.16 
1.0 1.027 102.70 100.25 
4.0 4.033 100.83  
8.0 7.892 98.65  
15.0 14.882 99.21  
 20.0 20.296 101.48  
 25.0 24.863 99.45  
± SD ¯Mean   100.63±1.40 99.82±0.67 
t   0.942(2.262)b 
F   4.40(19.35)b 
    
tablets  ®Cytomid
(250 mg FLT/tablet) 
1.0 1.003 100.30 99.68 
15.0 14.987 99.91 98.25 
25.0 25.365 101.46 100.25 
± SD ¯Mean   100.09±0.20 99.39±1.03 
t   1.54(2.776)b 
F   1.63(19.00)b 
aEach result is the average of three separate determinations. 




Table 5 Precision data of the proposed method for determination of FLT in pure form. 
Conc. (µg/mL) % Found ± SD % RSD % Error 
Intra-day precision 
0.4 
101.20± 0.34 0.34 0.20 
10.0 100.54± 1.34 1.33 0.77 
25.0 99.87 ± 1.50 1.50 0.90 
Inter-day precision 
0.4 99.54± 0.92 0.93 0.53 
10.0 100.20 ± 1.35 1.08 0.62 





Table 6 Final system suitability test parameters for FLT and DP by the proposed methoda 
 
Parameter 









retention (α) FLT DP FLT DP 
Result 10010 3642 2.41 1.00 6.30 2.30 




Table 7 kinetic parameters for the degradation of FLT under acidic and alkaline conditions 
 
 
Condition Temperature (°C) k (min-1) t½ (min) Ea (kJ/mol) Arrhenius equation 
HCl (0.3 M) 70 2.78×10-3 249 79.4 Log k= 9.60 – (4.15/T) 
80 9.06×10-3 77  
90 1.37×10-2 51  
100 2.89×10-2 24  
NaOH (0.03 M) 60 1.03×10-2 68 52.0 Log k= 6.14 – (2.72/T) 
70 1.63×10-2 43   
80 3.25×10-2 22   
90 2-4.46 ×10 15   
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Fig. 1 Representative chromatograms for FLT (20.0 µg/mL) after exposure to (A) alkaline degradation 
(0.03 M NaOH at 90 °C for 30 min) and (B) acidic degradation (0.3 M HCl at 90 °C for 30 min), 





































Fig. 2 Semi-logarithmic plots for the first-order degradation of FLT under (A) acidic (0.3 M HCl) and 


























































































































R = H+            in case of acidic hydrolysis
R= Na+           in case of alkaline hydrolysis
Flutamide 4-Nitro-3-trifluoromethyl aniline
(MW = 276.21) (MW = 206.12)
 
 






















(MW = 206.12) 
25 
 
